FUNDING
Company Profile
Assort Health builds AI voice agents that automate patient access workflows for healthcare organizations, including scheduling, intake, referrals, and insurance verification.
Founded 2023San Francisco, California$222M raised$1.2B valuation
Investors
Menlo VenturesLightspeed Venture PartnersFelicisFirst Round CapitalChemistryLiquid 2 VenturesQuiet CapitalA* Capital
Compare with
vs Tenon Medicalvs Jupiter Neurosciencesvs Ollin Biosciencesvs Triveni Biovs Scribe Therapeuticsvs Celea Therapeuticsvs PureTechvs OneMedNetvs Encore Medicalvs Flare Therapeuticsvs AEON Biopharmavs Apnimedvs Shionogivs Sanofivs Drug Farmvs Attovia Therapeuticsvs Chai Discoveryvs Colossal Biosciences
Funding & Valuation History
from our coverage| Date | Event | Amount | Valuation | Source |
|---|---|---|---|---|
| Jun 24, 2026 | Assort Health Raises $120M Series C at a $1.2B Valuation for Healthcare AI Agents | $120M | $1.2B | Story → |
Assort Health FAQ
- What is Assort Health's valuation in 2026?
- Assort Health was last valued at $1.2B in its most recent funding round.
- How much has Assort Health raised?
- Assort Health has raised approximately $222M in total funding to date.
- Is Assort Health publicly traded?
- No. Assort Health is privately held, last valued at $1.2B.
- Who are Assort Health's investors?
- Assort Health's investors include Menlo Ventures, Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Liquid 2 Ventures, Quiet Capital, A* Capital.
Coverage Timeline
newest firstAll Coverage
FUNDING$650M+ combined across 4 vertical rounds
Vertical AI Series A Rounds Are Quietly Getting Bigger
A cluster of recent Series A and C rounds -- General Intuition's $320M, RunPod's $100M and Assort Health's $120M among them -- shows vertical AI applications commanding round sizes once reserved for infrastructure megadeals.
FUNDING
Assort Health Raises $120M Series C at a $1.2B Valuation for Healthcare AI Agents
FUNDING$120M
Assort Health Raises $120M Series C at a $1.2B Valuation for Healthcare AI Agents
Assort Health raised a $120 million Series C led by Menlo Ventures at a $1.2 billion post-money valuation, vaulting the patient-access automation startup into unicorn territory. Its AI agents handle scheduling, intake, referrals, document processing and front-desk support for healthcare providers -- one of the clearest examples of AI moving from chatbot demos to embedded, revenue-bearing clinical workflows.